The therapeutic effect of low-dose methimazole on hyperthyroidism patients and its impact on thyroid volume and calcitonin levels
10.3760/cma.j.cn431274-20230505-00616
- VernacularTitle:小剂量甲巯咪唑治疗甲状腺功能亢进症患者的疗效及对甲状腺体积、降钙素水平的影响
- Author:
Jing HUANG
1
;
Wenchun YE
;
Xiangming FANG
;
Yan QIAO
;
Juan LI
Author Information
1. 电子科技大学医学院附属绵阳医院 绵阳市中心医院内分泌科，绵阳 621000
- Keywords:
Methimazole;
Hyperthyroidism;
Calcitonin;
Thyroid function tests
- From:
Journal of Chinese Physician
2024;26(4):560-563
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To analyze the effects of low-dose methimazole treatment on thyroid volume and calcitonin levels in patients with hyperthyroidism.Methods:A total of 100 hyperthyroidism patients who were treated at the Mianyang Central Hospital from January to June 2019 were selected and randomly divided into a control group (50 cases) and an observation group (50 cases) using a random number table method. The control group was treated with once a day and 30 mg/dose of methimazole, while the observation group was treated with twice a day and 10 mg/dose of methimazole. Thyroid volume, and thyroid function [Thyroid growth hormone (TSH), free triiodothyronine (FT3), free thyroxine (FT4), and thyroid stimulating hormone receptor antibody (TRAb)] before and after treatment in two groups of patients, the changes in serum levels of calcitonin (CT), visfatin, tumor necrosis factor-α (TNF-α), and interleukin-6 (IL-6) were compared. The clinical efficacy of two groups were also compared.Results:The total clinical effective rate of the observation group was higher than that of the control group ( P<0.05). After treatment, the thyroid volume in the observation group was significantly smaller than that in the control group, and the CT level was significantly lower than that in the control group (all P<0.05). After treatment, the TSH level in the observation group was significantly higher than that in the control group, while the levels of FT3, FT4, and TRAb were significantly lower than those in the control group (all P<0.05). After treatment, the levels of Visfatin, TNF-α, and IL-6 in the observation group were significantly lower than those in the control group (all P<0.05). Conclusions:Low dose methimazole can improve thyroid function, reduce thyroid volume, lower body CT and inflammation levels in patients with hyperthyroidism, and has a better therapeutic effect.
